METFORMIN Drug Patent Profile

When do Metformin patents expire, and what generic alternatives are available?

Metformin is a drug marketed by Annora Pharma, Bionpharma, Saptalis Pharms, Vistapharm Llc, Actavis Elizabeth, Actavis Labs Fl Inc, Ajanta Pharma Ltd, Alignscience Pharma, Alkem Labs Ltd, Amneal Pharms Ny, Apotex, Aurobindo Pharma, Aurobindo Pharma Ltd, Barr, Cspc Ouyi, Glenmark Pharms Ltd, Granules, Harman Finochem, Impax Labs, Inventia, Ivax Sub Teva Pharms, Laurus, Lupin Ltd, Macleods Pharms Ltd, Marksans Pharma, Medicap Labs, Micro Labs, Mpp Pharma, Mylan Pharms Inc, Nostrum Pharms Llc, Novast Labs, Pharmobedient, Prinston Inc, Qingdao Baheal Pharm, Ranbaxy Labs Ltd, Regcon Holdings, Rk Pharma, Sandoz, Sciegen Pharms, Sun Pharm, Sun Pharm Inds (in), Sun Pharm Industries, Teva, Torrent, Torrent Pharms Ltd, Twi Pharms, Unichem, Utopic Pharms, Watson Labs Inc, Yichang Humanwell, Zydus Lifesciences, Aarxion Anda Hlding, Alkem, Aurobindo, Chartwell, Dr Reddys Labs Inc, Epic Pharma Llc, Granules India, Heritage Pharma, Indicus Pharma, Ipca Labs Ltd, Mylan, Provident Pharm, Senores Pharms, Sun Pharm Inds Inc, Sunshine, Torrent Pharms, Watson Labs, Watson Labs Florida, Zydus Hlthcare, and Zydus Pharms Usa. and is included in one hundred and four NDAs.

The generic ingredient in METFORMIN is metformin hydrochloride. There are forty-nine drug master file entries for this compound. Eighty suppliers are listed for this compound. Additional details are available on the metformin hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Metformin

A generic version of METFORMIN was approved as metformin hydrochloride by CHARTWELL on January 24^th, 2002.

Summary for METFORMIN

US Patents:	0
Applicants:	71
NDAs:	104
Drug Prices:	Drug price information for METFORMIN
Drug Sales Revenues:	Drug sales revenues for METFORMIN
DailyMed Link:	METFORMIN at DailyMed

See drug prices for METFORMIN

See drug sales revenues for METFORMIN

US Patents and Regulatory Information for METFORMIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Prinston Inc	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	208880-002	Sep 10, 2018	AB	RX	No	No
Utopic Pharms	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	213394-001	Aug 3, 2021		DISCN	No	No
Impax Labs	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	076985-001	Sep 13, 2005		DISCN	No	No
Glenmark Pharms Ltd	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	212969-002	Nov 25, 2019	AB3	RX	No	No
Marksans Pharma	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET;ORAL	090888-003	Mar 12, 2012	AB	RX	No	No
Ipca Labs Ltd	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET;ORAL	078422-001	Aug 6, 2007		DISCN	No	No
Sciegen Pharms	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	214629-001	Feb 22, 2022	AB2	RX	No	No